Deerfield Management’s BlossomHill Therapeutics BLSM Stock Holding History
Bought
Maintained
Sold
Other funds holding BLSM
Deerfield Management's BLSM Position: Q3 2026 in Review
Deerfield Management opened a new position in BlossomHill Therapeutics (BLSM) in Q3 2026: 1,446,000 shares worth $27M. The stake represents 0.42% of the portfolio and ranks #52 among its holdings.
39 funds tracked by Wall St. Rank hold BLSM as of Q3 2026.
- Deerfield Management held 1,446,000 shares of BlossomHill Therapeutics worth $27M as of Q3 2026.
- BlossomHill Therapeutics was a new Deerfield Management position in Q3 2026.
- BlossomHill Therapeutics made up 0.42% of Deerfield Management's portfolio in Q3 2026, its #52 holding.
- 39 funds tracked by Wall St. Rank held BlossomHill Therapeutics as of Q3 2026.
Based on Deerfield Management's 13F filing for Q3 2026, filed 16 Nov 2026.